CYSLTR1 and Alzheimer disease: In the recent years, mounting evidence shows that CysLT1R is intimately associated with the occurrence and development of AD, and can mediate inflammatory response via the NF-κB pathway (Yu et al., 2005; Wang et al., 2011).